Professor Evan A Stein
Metabolic & Atherosclerosis Research Center, Cincinnati (United States of America)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
Future hurdles in PCSK9 - Inhibition.
Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session: PCSK9 inhibitors - For the many or the few?
What does the future hold?
Event: ESC CONGRESS 2014
Topic: Atherosclerosis
Session: The heterozygous familial hypercholesterolemia (HeFH) patient. Who am I? Why I matter to you
ESC 365 is supported by
